Healthway Compounding Pharmacy is proud to introduce an innovative medication for individuals seeking weight loss results: GLP-1 Semaglutide Rapid Dissolving Powder Capsules. For Michigan patients who prefer an alternative to traditional GLP-1 injections, this new option offers the potential of GLP-1 through a non-invasive, personalized approach.
What is GLP-1 and Why is Semaglutide a Game Changer?
GLP-1 (glucagon-like peptide-1) receptor agonists like semaglutide (main ingredient in Ozempic® and Wegovy®) and tirzepatide (main ingredient in Mounjaro® and Zepbound®) have been making waves in the medical community and in the media due to patients and celebrities exhibiting significant weight loss with the medication, and sharing their journeys on social media. It was originally developed for diabetes before its weight loss potential was discovered. These medications work by mimicking a hormone that suppresses appetite, slows gastric emptying, and promotes a feeling of fullness. As a result, patients consume fewer calories and are better able to manage their weight.
Semaglutide, specifically, has demonstrated remarkable results in clinical studies, helping patients achieve significant weight loss, especially when combined with lifestyle modifications such as diet and exercise. Traditionally administered as a once-weekly injection, Semaglutide has now become accessible in a new form—a rapid-dissolving powder capsule.
Related Article
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Netw Open. 2022 Sep 1;5(9):e2231982. doi: 10.1001/jamanetworkopen.2022.31982. PMID: 36121652; PMCID: PMC9486455.
“The findings of this cohort study suggest that semaglutide is clinically effective for weight loss at 3 and 6 months for people with overweight or obesity.”
Related Article
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Netw Open. 2022 Sep 1;5(9):e2231982. doi: 10.1001/jamanetworkopen.2022.31982. PMID: 36121652; PMCID: PMC9486455.
“The findings of this cohort study suggest that semaglutide is clinically effective for weight loss at 3 and 6 months for people with overweight or obesity.”
Why Choose Rapid Dissolving Powder Capsule Semaglutide (GLP-1)?
While injectable Semaglutide has been widely accepted as it was first to market, some patients may find injections inconvenient, intimidating, or uncomfortable.
The rapid-dissolving powder capsule provides a needle-free, easy-to-use alternative that fits seamlessly into daily routines.
It’s important to fill semaglutide prescriptions with GLP-1 experts.
Here are some of the key considerations:
- Ease of Use: Capsules are taken orally, eliminating the need for needles or injection training.
- Enhanced Absorption: The rapid-dissolving formulation ensures absorption in the gastrointestinal tract for optimal results.
- Customization: Compounded capsules can be tailored to meet individual dosage needs, aiming for the best possible outcomes for each patient.
- Discreet and Convenient: Capsules are portable and can be taken anytime, anywhere, without the need for refrigeration or special handling.
Michigan Practitioners, Weight Loss Clinics, & Med Spas
Are you interested in prescribing Rapid Dissolving Powder Capsule Semaglutide (GLP-1), but want to learn more? Ask our GLP-1 pharmacists your burning questions.
Who May Benefit from Semaglutide Capsules?
Semaglutide capsules are an excellent option for individuals who:
- Struggle with obesity or are overweight and have a related health condition (e.g., type 2 diabetes, high blood pressure, more).
- Prefer a needle-free alternative to injections.
- Are committed to a long-term weight management plan that includes healthy eating and physical activity.
However, as with any medication, a healthcare provider’s guidance is essential. Patients should consult their physician to determine whether Semaglutide capsules are the right choice for their weight loss journey.
Real Patient Reviews
“Using for weight maintenance after having lost nearly 80# over the past year. Working very well for me! I’m so grateful my doctor discovered this affordable option!”
– SR
“Healthway’s customer service has been nothing short of stellar! Very responsive, extremely polite, and most important, very knowledgeable and confident about their medication. I have experienced -20lbs in a month and half with zero side effects that were explained prior to using their Semaglutide dissolving pill.”
– AS
Why is Weight Loss Important for Michigan?
According to America’s Health Rankings:
35.4%
Percentage of Michigan adults who have a body mass index (BMI) of 30.0 or higher based on reported height and weight
Addressing obesity and achieving a healthier Body Mass Index (BMI) can have a profound cascading effect on overall health by reducing the risk or severity of numerous obesity-related conditions.
Losing excess weight may:
- Lower blood pressure
- Reducing the risk of hypertension and heart disease
- Improve insulin sensitivity, helping prevent or manage type 2 diabetes
- Ease stress on joints, alleviating symptoms of osteoarthritis and improving mobility
- Better sleep quality, reducing the risk of sleep apnea
- Reducing the risk of depression and anxiety.
Overall, prioritizing weight management may lead to improved longevity, better quality of life, and a reduced burden of chronic diseases.
How Healthway Compounding Pharmacy Makes a Difference
As Michigan’s leading PCAB-accredited compounding pharmacy, Healthway Compounding Pharmacy specializes in creating customized medications to meet unique patient needs. Our team of experts works closely with patients and their healthcare providers to develop individualized solutions that prioritize safety and efficacy.
We are committed to maintaining the highest standards of quality and precision in every medication. Our state-of-the-art compounding lab allows us to produce Semaglutide rapid-dissolving powder capsules with consistent potency and purity, giving patients confidence.
Serving Michigan’s Diverse Communities
Healthway Compounding Pharmacy is proud to serve patients across Michigan, including those in Saginaw, Traverse City, Alpena, Petoskey, and the Upper Peninsula. We understand that every patient is unique, and our goal is to provide accessible, high-quality compounded medications tailored to help patients reach their goals.
It’s Time to Take the Next Step in Your Weight Loss Journey
If you’re ready to explore a groundbreaking alternative to weight loss injections, Healthway Compounding Pharmacy is here to help. Contact us today to learn more about GLP-1 medication, Semaglutide Rapid Dissolving Powder Capsules, and how they may support your weight loss goals. Proper nutritional supplementation is also important, we can help you with recommendations.
Let’s work together to create a healthier, happier you—because your journey is as unique as you are.
References
Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2023). Semaglutide for the treatment of obesity. Trends in cardiovascular medicine, 33(3), 159-166. Link
Christou, G. A., Katsiki, N., Blundell, J., Fruhbeck, G., & Kiortsis, D. N. (2019). Semaglutide as a promising antiobesity drug. Obesity Reviews, 20(6), 805-815. Link
Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2023). Semaglutide for the treatment of overweight and obesity: a review. Diabetes, Obesity and Metabolism, 25(1), 18-35. Link
Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., … & Acosta, A. (2022). Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open, 5(9), e2231982-e2231982. Link
Wilding JPH, Batterham RL, Calanna S, et al. ; STEP 1 Study Group . Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Link